Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trial
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-25
DOI
10.1007/s10549-021-06216-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM)
- (2020) Laura Orlando et al. BREAST
- Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemics
- (2020) Johny E. Fares et al. CANCER TREATMENT REVIEWS
- Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?
- (2019) Marina Elena Cazzaniga et al. OncoTargets and Therapy
- Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group
- (2018) Hans Wildiers et al. LANCET ONCOLOGY
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Clinical overview of metronomic chemotherapy in breast cancer
- (2015) Elisabetta Munzone et al. Nature Reviews Clinical Oncology
- Metronomics: towards personalized chemotherapy?
- (2014) Nicolas André et al. Nature Reviews Clinical Oncology
- A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
- (2011) Zacharenia Saridaki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Duration of Chemotherapy for Metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2011) Alessandra Gennari et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment strategy for HER2-positive breast cancer
- (2010) Hirofumi Mukai International Journal of Clinical Oncology
- Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study
- (2010) Michael Andersson et al. JOURNAL OF CLINICAL ONCOLOGY
- Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
- (2009) Claire Banissi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer
- (2009) E. Briasoulis et al. CLINICAL CANCER RESEARCH
- Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer
- (2008) Silvia Dellapasqua et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now